JP2003532724A5 - - Google Patents

Download PDF

Info

Publication number
JP2003532724A5
JP2003532724A5 JP2001582319A JP2001582319A JP2003532724A5 JP 2003532724 A5 JP2003532724 A5 JP 2003532724A5 JP 2001582319 A JP2001582319 A JP 2001582319A JP 2001582319 A JP2001582319 A JP 2001582319A JP 2003532724 A5 JP2003532724 A5 JP 2003532724A5
Authority
JP
Japan
Prior art keywords
formula
compounds
compound
pharmaceutically acceptable
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001582319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003532724A (ja
Filing date
Publication date
Priority claimed from GBGB0011071.8A external-priority patent/GB0011071D0/en
Application filed filed Critical
Publication of JP2003532724A publication Critical patent/JP2003532724A/ja
Publication of JP2003532724A5 publication Critical patent/JP2003532724A5/ja
Pending legal-status Critical Current

Links

JP2001582319A 2000-05-08 2001-05-07 ソマトスタチン誘導体に親和性を有する、ヒダントイン誘導体 Pending JP2003532724A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0011071.8 2000-05-08
GBGB0011071.8A GB0011071D0 (en) 2000-05-08 2000-05-08 Organic compounds
PCT/EP2001/005162 WO2001085718A1 (en) 2000-05-08 2001-05-07 Hydantoin derivatives with affinity for somatostatin receptors

Publications (2)

Publication Number Publication Date
JP2003532724A JP2003532724A (ja) 2003-11-05
JP2003532724A5 true JP2003532724A5 (https=) 2008-06-19

Family

ID=9891182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001582319A Pending JP2003532724A (ja) 2000-05-08 2001-05-07 ソマトスタチン誘導体に親和性を有する、ヒダントイン誘導体

Country Status (11)

Country Link
US (1) US7019004B2 (https=)
EP (1) EP1282617B1 (https=)
JP (1) JP2003532724A (https=)
AT (1) ATE441642T1 (https=)
AU (1) AU7399801A (https=)
CA (1) CA2405968A1 (https=)
DE (1) DE60139770D1 (https=)
ES (1) ES2330305T3 (https=)
GB (1) GB0011071D0 (https=)
PT (1) PT1282617E (https=)
WO (1) WO2001085718A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AU2002363655A1 (en) * 2001-11-14 2003-05-26 Novartis Ag Non-peptide somatostatin receptor ligands
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
SI2384753T1 (sl) 2003-08-29 2016-06-30 The Brigham And Women's Hospital, Inc. Hidantoinski derivati kot inhibitorji celične nekroze
CA2772760A1 (en) 2008-12-23 2010-07-01 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
EP3229807A4 (en) 2014-12-11 2018-10-17 President and Fellows of Harvard College Inhibitors of cellular necrosis and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859190A (en) * 1997-02-04 1999-01-12 Trega Biosciences, Inc. Combinatorial libraries of hydantoin and thiohydantoin derivatives, methods of making the libraries and compounds therein
FR2796945B1 (fr) * 1999-07-30 2002-06-28 Sod Conseils Rech Applic Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
AU2002363655A1 (en) * 2001-11-14 2003-05-26 Novartis Ag Non-peptide somatostatin receptor ligands
US7189856B2 (en) * 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands

Similar Documents

Publication Publication Date Title
EP4148050B1 (en) Novel acid secretion inhibitor and use thereof
JPWO2003037881A1 (ja) 酢酸アニリド誘導体のα型又はβ型結晶
CN112898345A (zh) 核苷酸类似物
CA2511479A1 (en) Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
CA2694567A1 (en) Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
JP2003532724A5 (https=)
KR20110013411A (ko) (f-19)-표지된 l-글루탐산 및 l-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법
TWI432423B (zh) 3-二取代吲哚-2-酮衍生物,其製備及其治療用途
JP2010512355A (ja) 癌の処置のためのジフェニルオキシ−インドール−2−オン化合物のプロドラッグ
JP4393376B2 (ja) フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用
EP1282617B1 (en) Hydantoin derivatives with affinity for somatostatin receptors
TW448176B (en) Phenylcyclohexylcarboxamides, their preparation and pharmaceutical composition containing the same
US6919379B2 (en) Compounds useful in reflux disease
WO2000009115A1 (en) Grp receptor ligands
JP4567889B2 (ja) ((アミノイミノメチル)アミノ)アルカンカルボキシアミドおよび治療におけるその適用
JP4927566B2 (ja) Par−2アゴニスト
US20070004777A1 (en) Methods for treating or preventing acute myelogenous leukemia
HUP0204476A2 (en) Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical compositions containing them
WO2006035936A1 (ja) Par-2アンタゴニスト
CN111094259A (zh) 止痛化合物
JPH06506451A (ja) Gem−ジホスホン酸ニトロソカルバモイル誘導体、その製造方法およびそれを含む医薬組成物
JP2001181251A (ja) アスピリン誘導体、その製造方法、並びにこれを有効成分として含有する抗炎症剤
RU2263669C2 (ru) Замещенные 8,8a-дигидро-3ah-индено [1,2-d] тиазолы, способ их получения и их применение в качестве лекарственных средств
JPS5857349A (ja) ジペプチド誘導体
EP0270292A2 (en) Radiation sensitizers